Frontlight ResearchEarly access
Ovarian cancer trials in United States
348 trials · From ClinicalTrials.gov, checked 18 November 2026. Ask the study team whether a trial fits you.
- No phaseTaking peopleReal World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring
- Where
- Canton, Chapel Hill, Cleveland, Durham, Evanston, Massillon, New Haven
- Age
- 18 years and over
- People
- 25
- Run by
- Carevive Systems, Inc.
See details and how to joinNCT05974150 - No phaseTaking peopleCancer Experience Registry (CER) for Cancer Patients and Caregivers
- Where
- Washington D.C.
- Age
- 18 years and over
- People
- 15,000
- Run by
- Cancer Support Community, Research and Training Institute, Philadelphia
See details and how to joinNCT02333604 - Phase 1/2Taking peopleAdministering Peripheral Blood Lymphocytes Transduced With a CD70-Binding Chimeric Antigen Receptor to People With CD70 Expressing Cancers
- Where
- Bethesda
- Age
- 18 years to 72 years
- People
- 124
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT02830724 - Phase 2Taking people18F-Fibroblast Activation Protein Inhibitor ([18F]FAPI-74) PET Imaging for Cancer Detection
- Where
- Bethesda
- Age
- 18 years to 120 years
- People
- 320
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT06503146 - Phase 1Taking peopleA Phase 1 Study of LNCB74 in Advanced Solid Tumors
- Where
- Boston, Buffalo, Cleveland, Edgewood, Falls Church, Hackensack, Houston, Nashville, Newport Beach, New York, Philadelphia, Pittsburgh, Salt Lake City, San Antonio, St Louis
- Age
- 18 years and over
- People
- 145
- Run by
- LigaChem Biosciences, Inc.
See details and how to joinNCT06774963 - Phase 2Taking peopleDB-1311 in Combination With BNT327 or DB-1305 in Advanced/Metastatic Solid Tumors
- Where
- Anderson, Atlanta, Bethesda, Charleston, Florida City, Houston, Lincoln, Los Angeles, New York, Portland, Puyallup, Spokane, Virginia Beach, Wheat Ridge
- Age
- 18 years and over
- People
- 750 worldwide
- Run by
- DualityBio Inc.
See details and how to joinNCT06953089 · EU 2025-523895-22-00 - No phaseTaking peopleAvera Cancer Sequencing and Analytics Protocol (ASAP)
- Where
- Aberdeen, Marshall, Mitchell, Pierre, Sioux Falls, Yankton
- Age
- 18 years and over
- People
- 25,000
- Run by
- Avera McKennan Hospital & University Health Center
See details and how to joinNCT05142033 - Phase 1Taking peopleA Study of MGC026 in Participants With Advanced Solid Tumors
- Where
- Grand Rapids, Houston, Lake Success, Los Angeles, Portland, West Valley City
- Age
- 18 years and over
- People
- 394 worldwide
- Run by
- MacroGenics
See details and how to joinNCT06242470 - Phase 1/2Taking peopleLead-212 PSV359 Therapy for Patients With Solid Tumors
- Where
- Cleveland, Columbus, Dallas, Houston, Kansas City, Lexington, Los Angeles, Madison, Miami, New York, Omaha, Pittsburgh, Rochester, St Louis
- Age
- 18 years to 90 years
- People
- 112
- Run by
- Perspective Therapeutics
See details and how to joinNCT06710756 - Phase 3Taking peopleStudy of Trastuzumab Deruxtecan With Bevacizumab Versus Bevacizumab Monotherapy for First-line Maintenance in HER2-Expressing Ovarian Cancer (DESTINY-Ovarian01)
- Where
- Ann Arbor, Bethlehem, Billings, Boston, Burbank, Centerville, Chapel Hill, Evanston, Fort Lauderdale, Grand Rapids, Indianapolis, Jupiter, La Jolla, Lancaster, Madison, Miami Beach, Minneapolis, Nashville, New York, Orlando, Palo Alto, Paramus, Portland, Salt Lake City, Savannah, Shreveport, Sioux Falls, St. Petersburg, Towson
- Age
- 18 years and over
- People
- 582 worldwide
- Run by
- Daiichi Sankyo
See details and how to joinNCT06819007 · EU 2024-516982-35-00 - Phase 1/2Taking peopleA Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations
- Where
- Austin, Boston, Cleveland, Duarte, Fairfax, Houston, Huntersville, Irvine, Milwaukee, Nashville, Omaha, Orlando, Rochester, San Antonio, St Louis, West Valley City, Zion
- Age
- 18 years and over
- People
- 248 worldwide
- Run by
- Terremoto Biosciences Inc.
See details and how to joinNCT07109726 - Phase 1/2Taking people[18F]FPyQCP PET Imaging of Fibroblast Activation Protein in Selected Oncology Indications
- Where
- Dallas, New York
- Age
- 18 years to 80 years
- People
- 71
- Run by
- Blue Earth Diagnostics
See details and how to joinNCT07432633 - Phase 2Not yet taking people in United StatesAdjuvant Therapeutic Cancer Vaccine (AST-201, pUMVC3-hIGFBP-2) in Patients With Advanced Ovarian Cancer
- Where
- Seattle
- Age
- 18 years and over
- People
- 98
- Run by
- Aston Sci. Inc.
See details and how to joinNCT05794659 - Phase 1Taking peopleDBC-664 in Adult Patients With Solid Tumors
- Where
- Denver, East Brunswick, Grand Rapids, Lake Success, Nashville, San Antonio, St Louis
- Age
- 18 years and over
- People
- 210
- Run by
- Duboce Biopharmaceuticals, Inc.
See details and how to joinNCT07705035 - No phaseTaking peopleInternational PPB/DICER1 Registry
- Where
- Minneapolis
- Age
- 0 Minutes to 100 years
- People
- 3,400
- Run by
- Children's Hospitals and Clinics of Minnesota
See details and how to joinNCT03382158 - Phase 2/3Taking peopleA Study of Raludotatug Deruxtecan (R-DXd) in Subjects With Platinum-resistant, High-grade Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
- Where
- Anchorage, Bay Shore, Bedford, Charleston, Charlotte, Charlottesville, Conroe, Coral Gables, Dallas, Deerfield Beach, Durham, Edgewood, Eugene, Fort Worth, Hilliard, Houston, Indianapolis, Lake Mary, Lake Success, League City, Miami, Miami Beach, Milwaukee, Mineola, New Haven, New York, Oklahoma City, Paramus, Philadelphia, Plantation, Seattle, Sioux Falls, Springfield, St Louis, Teaneck, Tulsa
- Age
- 18 years and over
- People
- 860 worldwide
- Run by
- Daiichi Sankyo
See details and how to joinNCT06161025 · EU 2023-507914-28-00 - Phase 1/2Taking peopleA Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
- Where
- Amarillo, Chattanooga, Dallas, Fairfax, Germantown, Los Angeles, Minneapolis, Nashville, New York, Pearland, Salt Lake City, Skokie, Wenatchee, Westbury, White Plains, Whittier
- Age
- 18 years and over
- People
- 680 worldwide
- Run by
- Daiichi Sankyo
See details and how to joinNCT06330064 · EU 2023-509632-26-00 - No phaseTaking peopleInternational Ovarian & Testicular Stromal Tumor Registry
- Where
- Minneapolis
- People
- 500
- Run by
- Children's Hospitals and Clinics of Minnesota
See details and how to joinNCT01970696 - Phase 3Enrolling by invitationSafety Extension Study for Subjects With HR+, HER2- Breast Cancer for Subjects Who Have Completed the OVELIA Study
- Where
- Austin, Chattanooga, Columbia, Dallas, East Syracuse, Fayetteville, Fort Lauderdale, Greenbrae, Lexington, Longview, Louisville, Lubbock, Nashville, New Braunfels, Plano, Seattle, Wynnewood
- Age
- 18 years to 51 years
- People
- 250 worldwide
- Run by
- Tolmar Inc.
See details and how to joinNCT05645536 - Phase 2Taking peopleA Study of Avutometinib, Defactinib, and Letrozole in People With Low-Grade Serous Ovarian Cancer
- Where
- Atlanta, Basking Ridge, Commack, East White Plains, Middletown, Montvale, New York, Uniondale
- Age
- 18 years and over
- People
- 20
- Run by
- Memorial Sloan Kettering Cancer Center
See details and how to joinNCT06394804 - Phase 1/2Taking peopleA Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
- Where
- Austin, Baton Rouge, Birmingham, Boston, Chattanooga, Cincinnati, Columbia, Dallas, Denver, East Syracuse, Fairfax, Flower Mound, Fort Myers, Hinsdale, Houston, Indianapolis, Jacksonville, Lake Success, Little Rock, Los Angeles, Maple Grove, Maumee, Memphis, Nashville, New York, Oklahoma City, Orlando, Philadelphia, Portland, Rochester, Salt Lake City, San Antonio, Santa Barbara, Santa Rosa, Sarasota, Scottsdale, Seattle, St Louis, Washington D.C., West Palm Beach
- Age
- 18 years and over
- People
- 542 worldwide
- Run by
- Artios Pharma Ltd
See details and how to joinNCT04657068 - Phase 1Taking peopleGB-5267 for the Treatment Platinum-Resistant Ovarian, Peritoneal, or Fallopian Tube Cancer
- Where
- Buffalo
- Age
- 18 years and over
- People
- 33
- Run by
- Roswell Park Cancer Institute
See details and how to joinNCT07489287 - Phase 1/2Taking peopleA Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
- Where
- Atlanta, Austin, Canton, Celebration, Charleston, Cincinnati, Dallas, Dayton, Detroit, Fairfax, Greenville, Las Vegas, Los Angeles, Louisville, Margate, Nashville, New York, Orlando, Plantation, Saint Paul, Santa Monica, Spokane, Tamarac, Tucson
- Age
- 18 years and over
- People
- 862 worldwide
- Run by
- DualityBio Inc.
See details and how to joinNCT05914116 - Phase 1Taking peopleAOH1996 for the Treatment of Refractory Solid Tumors
- Where
- Duarte, Long Beach, Scottsdale
- Age
- 18 years and over
- People
- 92
- Run by
- City of Hope Medical Center
See details and how to joinNCT05227326 - Phase 1Taking peopleSafety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma
- Where
- Atlanta, Denver, Los Angeles, Milwaukee, Newport, New York, Rochester, San Antonio
- Age
- 18 years and over
- People
- 100
- Run by
- Nammi Therapeutics Inc
See details and how to joinNCT06582017